Skip to main content
Veterinary Medicines

Kaltetan forte, 458.4 mg/ml + 125 mg/ml + 20 mg/ml solution for infusion for horses, cattle and pigs

Authorised
  • Sodium glycerophosphate pentahydrate
  • Magnesium chloride hexahydrate
  • CALCIUM GLUCONATE FOR INJECTION

Identifikacija zdravila

Ime zdravila:
Kaltetan forte, 458.4 mg/ml + 125 mg/ml + 20 mg/ml solution for infusion for horses, cattle and pigs
Kaltetan forte 458,4 mg/1 ml + 125 mg/1 ml + 20 mg/ml Roztwór do infuzji
Učinkovina:
Pot uporabe:
  • Intravenska uporaba

Podatki o zdravilu

Učinkovina / Jakost:
  • Na voljo samo v English
    20.00
    milligram(s)
    /
    1.00
    millilitre(s)
  • Na voljo samo v English
    125.00
    milligram(s)
    /
    1.00
    millilitre(s)
  • Na voljo samo v English
    458.40
    milligram(s)
    /
    1.00
    millilitre(s)
Farmacevtska oblika:
  • Raztopina za infundiranje
Withdrawal period by route of administration:
  • Intravenous use
    • Horse
      • Milk
        5
        week
    • govedo
      • Meat and offal
        5
        week
    • Pig
      • Meat and offal
        5
        week
Anatomsko-terapevtsko-kemična veterinarska oznaka (ATCvet):
  • QA12AX
Status dovoljenja:
  • Valid
Authorised in:
  • Poland
Available in:
  • Poland
Opis ovojnine:

Dodatne informacije

Entitlement type:
Imetnik dovoljenja za promet z zdravilom:
  • Vet-Agro Multi-Trade Company Sp. z o.o.
Marketing authorisation date:
Proizvodna mesta, odgovorna za sproščanje serij:
  • Multi-Trade Company "Vet-Agro" Sp. z o.o.
Pristojni organ:
  • Office For Registration Of Medicinal Products Medical Devices And Biocidal Products
Številka dovoljenja :
  • 3172
Datum spremembe statusa dovoljenja:
Številka postopka:
  • PL/V/0110/002
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."